These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 36471375)

  • 1. Role of apolipoprotein C1 in lipoprotein metabolism, atherosclerosis and diabetes: a systematic review.
    Rouland A; Masson D; Lagrost L; Vergès B; Gautier T; Bouillet B
    Cardiovasc Diabetol; 2022 Dec; 21(1):272. PubMed ID: 36471375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein C1: Its Pleiotropic Effects in Lipid Metabolism and Beyond.
    Fuior EV; Gafencu AV
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31779116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of lipoprotein lipase and hepatic lipase on the transformation of VLDL and HDL during lipolysis of VLDL.
    Murdoch SJ; Breckenridge WC
    Atherosclerosis; 1995 Dec; 118(2):193-212. PubMed ID: 8770314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bexarotene induces dyslipidemia by increased very low-density lipoprotein production and cholesteryl ester transfer protein-mediated reduction of high-density lipoprotein.
    de Vries-van der Weij J; de Haan W; Hu L; Kuif M; Oei HL; van der Hoorn JW; Havekes LM; Princen HM; Romijn JA; Smit JW; Rensen PC
    Endocrinology; 2009 May; 150(5):2368-75. PubMed ID: 19147676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoprotein lipase enhances the cholesteryl ester transfer protein-mediated transfer of cholesteryl esters from high density lipoproteins to very low density lipoproteins.
    Tall AR; Sammett D; Vita GM; Deckelbaum R; Olivecrona T
    J Biol Chem; 1984 Aug; 259(15):9587-94. PubMed ID: 6746661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E.
    Dergunov AD; Smirnova EA; Merched A; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
    Biochim Biophys Acta; 2000 Feb; 1484(1):29-40. PubMed ID: 10685028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In the absence of the low density lipoprotein receptor, human apolipoprotein C1 overexpression in transgenic mice inhibits the hepatic uptake of very low density lipoproteins via a receptor-associated protein-sensitive pathway.
    Jong MC; Dahlmans VE; van Gorp PJ; van Dijk KW; Breuer ML; Hofker MH; Havekes LM
    J Clin Invest; 1996 Nov; 98(10):2259-67. PubMed ID: 8941642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in particle size of high density lipoproteins during incubation with very low density lipoproteins, cholesteryl ester transfer protein and lipoprotein lipase.
    Newnham HH; Barter PJ
    Biochim Biophys Acta; 1992 May; 1125(3):297-304. PubMed ID: 1596518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human apolipoprotein C1 transgenesis reduces atherogenesis in hypercholesterolemic rabbits.
    Gautier T; Deckert V; Aires V; Le Guern N; Proukhnitzky L; Patoli D; Lemaire S; Maquart G; Bataille A; Xolin M; Magnani C; Masson D; Harscoët E; Da Silva B; Houdebine LM; Jolivet G; Lagrost L
    Atherosclerosis; 2021 Mar; 320():10-18. PubMed ID: 33497863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Constitutive inhibition of plasma CETP by apolipoprotein C1 is blunted in dyslipidemic patients with coronary artery disease.
    Pillois X; Gautier T; Bouillet B; Pais de Barros JP; Jeannin A; Vergès B; Bonnet J; Lagrost L
    J Lipid Res; 2012 Jun; 53(6):1200-9. PubMed ID: 22474067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of enhancement of cholesteryl ester transfer protein activity by lipolysis.
    Sammett D; Tall AR
    J Biol Chem; 1985 Jun; 260(11):6687-97. PubMed ID: 3838987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholesteryl ester transfer activity in liver disease and cholestasis, and its relation with fatty acid composition of lipoprotein lipids.
    Iglesias A; Arranz M; Alvarez JJ; Perales J; Villar J; Herrera E; Lasunción MA
    Clin Chim Acta; 1996 Apr; 248(2):157-74. PubMed ID: 8740580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of cholesteryl ester transfer protein-mediated cholesteryl ester mass transfer from high-density lipoprotein to low-density lipoprotein particles is a major feature of combined hyperlipidaemia.
    Guérin M; Bruckert E; Dolphin PJ; Chapman MJ
    Eur J Clin Invest; 1996 Jun; 26(6):485-94. PubMed ID: 8817163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High density lipoprotein cholesteryl ester metabolism in the pony, an animal species without plasma cholesteryl ester transfer protein activity: transfer of high density lipoprotein cholesteryl esters to lower density lipoproteins and the effect of the amount of fat in the diet.
    Geelen SN; Lemmens AG; Terpstra AH; Wensing T; Beynen AC
    Comp Biochem Physiol B Biochem Mol Biol; 2001 Sep; 130(2):145-54. PubMed ID: 11544085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro production of beta-very low density lipoproteins and small, dense low density lipoproteins in mildly hypertriglyceridemic plasma: role of activities of lecithin:cholester acyltransferase, cholesterylester transfer proteins and lipoprotein lipase.
    Chung BH; Segrest JP; Franklin F
    Atherosclerosis; 1998 Dec; 141(2):209-25. PubMed ID: 9862170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux.
    Guerin M; Egger P; Soudant C; Le Goff W; van Tol A; Dupuis R; Chapman MJ
    Atherosclerosis; 2002 Aug; 163(2):287-96. PubMed ID: 12052475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in composition and concentration of lipoproteins and elevated cholesteryl ester transfer in non-insulin-dependent diabetes mellitus (NIDDM).
    Elchebly M; Porokhov B; Pulcini T; Berthezène F; Ponsin G
    Atherosclerosis; 1996 Jun; 123(1-2):93-101. PubMed ID: 8782840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in high-density lipoprotein metabolism and reverse cholesterol transport in insulin resistance and type 2 diabetes mellitus: role of lipolytic enzymes, lecithin:cholesterol acyltransferase and lipid transfer proteins.
    Borggreve SE; De Vries R; Dullaart RP
    Eur J Clin Invest; 2003 Dec; 33(12):1051-69. PubMed ID: 14636288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VLDL-bound lipoprotein lipase facilitates the cholesteryl ester transfer protein-mediated transfer of cholesteryl esters from HDL to VLDL.
    Pruneta V; Pulcini T; Lalanne F; Marçais C; Berthezène F; Ponsin G; Moulin P
    J Lipid Res; 1999 Dec; 40(12):2333-9. PubMed ID: 10588959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Action of atorvastatin in combined hyperlipidemia : preferential reduction of cholesteryl ester transfer from HDL to VLDL1 particles.
    Guerin M; Lassel TS; Le Goff W; Farnier M; Chapman MJ
    Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):189-97. PubMed ID: 10634817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.